| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mizugaki M et al. | Microdetermination of 2,3-dinor-6-ketoprostaglandin F1 alpha in human urine using gas chromatography-high-resolution selected-ion monitoring. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:7952110 |
| Adatia I et al. | Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. | 1993 | Circulation | pmid:8222105 |
| Bordet JC et al. | Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. | 1993 | Am. J. Cardiol. | pmid:8352201 |
| Adatia I et al. | Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. | 1993 | Br Heart J | pmid:8435245 |
| Foulon I et al. | Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. | 1993 | Arterioscler. Thromb. | pmid:8443146 |
| Chen HI et al. | Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. | 1993 | Acta Physiol. Scand. | pmid:8452036 |
| Closa D et al. | Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. | 1993 | Dig. Dis. Sci. | pmid:7678383 |
| Benowitz NL et al. | Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. | 1993 | J. Am. Coll. Cardiol. | pmid:7691912 |
| Wennmalm A et al. | Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. | 1993 | Clin Physiol | pmid:8519161 |
| Ferretti A and Flanagan VP | Assay of urinary 2,3-dinor-6-oxo prostaglandin F1 alpha by gas chromatography-tandem mass spectrometry. | 1993 | J. Chromatogr. | pmid:8150859 |